Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features

Blood

Volumn 88, Issue 5, 1996, Pages 1824-1833

  Kizaki, Masahiro ^a   Matsushita, Hiromichi ^b   Takayama, Nobuyuki ^b   Muto, Akihiro ^b   Ueno, Hironori ^b   Awaya, Norihiro ^b   Kawai, Yohko ^b   Asou, Hiroya ^b   Kamada, Nanao ^b   Ikeda, Yasuo ^b  

^a KEIO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD33 ANTIGEN; CD38 ANTIGEN; CD7 ANTIGEN; CELL SURFACE MARKER; MICROSOMAL AMINOPEPTIDASE; RETINOIC ACID;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CELL DIFFERENTIATION; CELL LINE; CELL STRAIN HL 60; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CODON; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROMYELOCYTE; PROMYELOCYTIC LEUKEMIA; SEQUENCE ANALYSIS;

EID: 9544242743     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.5.1824.bloodjournal8851824     Document Type: Article

References (35)

1. Lotan R: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem Biophys Acta 605:33, 1980
2. Sporn MB, Roberts AB: Role of retinoids in differentiation and cartinogenesis. Cancer Res 43:3034, 1983
3. Breitman TR, Selonick SE, Collins SJ: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2986, 1980
4. Koeffler HP: Induction of differentiation of human acute myelogenous leukemia cells: Therapeutic implications. Blood 62:709, 1983
5. Bennett JM, Catavsky D, Daniel MT, Flandrin G, Gallon DAG, Gralnick HR, Sultan C: Proposal for the classification of the acute leukaemias (FAB cooperative group). Br J Haematol 33:451, 1976
6. Warrell RP Jr, deThe H, Wang ZY, Degos L: Acute promyelocytic leukemia. N Eng J Med 329:177, 1993
7. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu HT, Wang ZY: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
8. Castaigne S, Chomienne C, Daniel MT, Ballarini P, Berger R, Fenaux P, Degos L: All-frans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704, 1990
9. Warrell RP Jr, Frankel SR, Miller WH Jr, Sheinberg DA, Itri LM, Hittelman WN, Vyas S, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovski E: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385, 1991
10. Muindi J, Frankel SR, Miller WH Jr, Jakubowski A. Scheinberg DA, Young CW, Dmitrovski E, Warrell RP Jr: Continuous treatment with all-trans retinoic acid causes a progressive decrease in plasma concentrations: Implications for relapse and "resistance" in acute promyelocytic leukemia. Blood 79:299, 1992
11. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R: NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
12. Duprez E, Ruchaud S, Houge G, Martin-Thouvenin V, Valensi F, Kastner Ph, Berger R, Lanotte M: A retinoid acid "resistant" t(15;17) acute promyelocytic leukemia cell line: Isolation, morphological, immunological, and molecular features. Leukemia 6:1281, 1992
13. Gallagher RE, Bilello PA, Ferrari AC, Chang CS, Yen RWC, Nickols WA, Muly EM III: Characterization of differentiation inducer-resistant HL-60 cells. Leuk Res 9:967, 1985
14. Enomoto Y, Watanabe Y: Giant mitochondria with filamentous structures in bone marrow macrophages. J Electron Microsc 34:25, 1985
15. Kamada N, Dohy H, Okada K, Oguma N, Kuramoto A, Tanaka K, Uchino H: In vivo and in vitro activity of neutrophil alkaline phosphatase in acute myelocytic leukemia with 8;21 translocation. Blood 58:1213, 1981
16. Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Mutry VVVS, Dmitrovski E, Evans RM: Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR-α with a novel putative transcription factor. PML. Cell 66:663, 1991
17. Chromczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
18. Petkovich M, Brand NJ, Krust A, Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444, 1987
19. Robertson KA, Emani B, Collins SJ: Retinoic-acid resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80:1885, 1992
20. Li YP, Said F, Gallagher RE: Retinoic acid-resistant HL-60 cells exlusively contain mutant retinoic acid receptor-α. Blood 83:3298, 1994
21. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Grolnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 103:620, 1985
22. Drexler HG, Quentmeier H, MacLeod RAF, Uphoff CC, Hu Z-B: Leukemic cell lines: In vitro models for the study of acute promyelocytic leukemia. Leuk Res 19:681, 1995
23. Ball ED, Davis RB, Griffin JD, Mayer RJ, Davey FR, Arthur DC, Wurster-Hill D, Noll W, Elghetany T, Allen SL, Rai K, Lee EJ, Schiffer CA, Bloomfield CD: Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood 77:2242, 1991
24. Coco FL, Rossi GD, Pasqualetti D, Lopez M, Diverio D, Latagliata P, Fenu S, Mandelli F: CD7 positive acute myeloid leukemia: A subtype associated with cell immaturity. Br J Haematol 73:480, 1989
25. Zutter MM, Martin PJ, Hanke D, Kidd PG: CD7+ acute non-lymphocytic leukemia: Evidence for an early multipotential progenitor. Leuk Res 14:23, 1990
26. - acute leukmia: A syndrome of malignant pluripotent lymphohematopoietic cells. Blood 73:381, 1989
27. Kita K, Miwa H, Nakuse K, Kawakami K, Kobayashi T, Shirakawa S, Tanaka I, Ohta C, Tsutani H, Oguma S, Kyo T, Dohy H, Kamada N, Nasu K, Uchino H (The Japan Cooperative Group of Leukemia/Lymphoma): Clinical importance of CD? expression in acute myelocytic leukemia. Blood 81:2398, 1993
28. Leary AG, Yang YC, Clark SC, Gasson JC, Golde DW, Ogawa M: Recombinant gibbon interleukin-3 supports formation of human multilineage colonies and blast cell colonies in culture: Comparison with recombinant human granulocyte-macrophage colony-stimulating factor. Blood 70:1343, 1987
29. Zsebo KM, Wypych J, McNiece IK, Lu HS, Smith KA, Karkare SB, Sachdev RK, Yuschenkoff VN, Birkett NC, Williams LR, Satyagal VN, Tung W, Bosselman RA, Mendiaz EA, Langley KE: Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 63:195, 1990
30. Pratt MAC, Kralova J, McBurney MW: A dominant negative mutation of the alpha-retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol Cell Biol 10:6445, 1990
31. Collins SJ, Robertson KA, Mueller L: Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha). Mol Cell Biol 10:2154, 1990
32. Warrell RP Jr: Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications. Blood 82:1949, 1993
33. Fiorella PD, Napoli JL: Expression of cellular retinoic acid binding protein (CRABP) in Escherichia coli: Characterization and evidence that holo-CRABP is a substrate in retinoic acid metabolism. J Biol Chem 266:16572, 1991
34. Delva L, Monique C, Balitrand N, Guidez F, Miclea J-M, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L, Chomienne C: Resistance to all-trans RA (ATRA) therapy in relapsing acute promyelocytic leukemia: Study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 82:2175, 1993
35. Kizaki M, Ueno H, Yamazoe Y, Shimada M, Takayama N, Muto A, Matsushita H, Nakajima H, Morikawa M, Koeffler HP, Ikeda Y: Mechanisms of retinoid resistance in leukemic cells: Possible role of cytochrome P-450 and P-glycoprotein. Blood 87:725, 1996